PLEURAL MESOTHELIOMA
Clinical trials for PLEURAL MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new PLEURAL MESOTHELIOMA trials appear
Sign up with your email to follow new studies for PLEURAL MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill plus immunotherapy shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis study tests an experimental oral drug called Alintegimod (7HP349) combined with two immunotherapy drugs (ipilimumab and nivolumab) in people with advanced solid tumors like melanoma, lung, kidney, or liver cancer who have already tried other treatments. The goal is to see if…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: 7 Hills Pharma, LLC • Aim: Disease control
Last updated May 26, 2026 08:23 UTC
-
New drug targets Hard-to-Treat cancers with rare gene deletion
Disease control Recruiting nowThis early-stage study tests a new drug called IDE892, alone or with other medicines, in people with advanced solid tumors that lack a gene called MTAP. The goal is to see if the drug is safe and can shrink tumors. About 260 adults with certain cancers (like lung, stomach, bladde…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: PHASE1 • Sponsor: IDEAYA Biosciences • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Cancer diagnosis revolution: new platform aims to personalize treatment
Diagnosis Recruiting nowThis study is testing a new platform that uses advanced genetic and functional tests to better understand tumors from 300 people with various high-risk cancers, including leukemia, myeloma, and pancreatic cancer. The goal is to see if this detailed analysis can change the recomme…
Matched conditions: PLEURAL MESOTHELIOMA
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated May 22, 2026 13:54 UTC